Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Delayed Quote. Delayed  - 06/30 05:35:05 pm
74.92 EUR   +0.83%
06/29 MERCK : Big pharma companies react to Brexit
06/29 SANOFI : Icagen Acquires Sanofi's Oro Valley, Arizona Research Facil..
06/28 SANOFI : Boehringer signs deal for Sanofi assets
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals27,72082.1%29,79986.3% +7.5%
Vaccines3,97411.8%4,74313.7% +19.35%
Animal Health2,0766.1%---
Sales per Regions
20142015Delta
EUR (in Million)%EUR (in Million)%
Other Countries11,45333.9%11,83034.2% +3.29%
United States11,33933.6%12,24635.5% +8%
Europe7,93223.5%7,61322% -4.02%
France2,4747.3%2,2486.5% -9.14%
North America572.001.7%605.001.8% +5.77%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer & Director
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Group Chief Medical Officer & Executive VP
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,305,696,759 1,148,098,044 87.9% 3,956,708 0.3% 87.9%
Shareholders
NameEquities%
L'Oréal SA 118,227,307 9.19%
Norges Bank Investment Management 26,541,076 2.06%
Dodge & Cox 25,166,652 1.96%
The Vanguard Group, Inc. 23,175,589 1.80%
Berkshire Hathaway, Inc. (Investment Management) 22,169,930 1.72%
Amundi Asset Management SA (Investment Management) 19,493,009 1.51%
Plan d'Epargne Entreprise Sanofi Synthelabo 16,697,049 1.30%
BlackRock Fund Advisors 13,848,275 1.08%
Lyxor International Asset Management SAS 13,508,207 1.05%
THEAM SAS 13,015,690 1.01%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,418,39622.7%9,342,300,716 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%866,679,799 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%735,605,719 USD
Sanofi (SAN) 3,956,7080.31%324,590,123 USD
Zentiva SA (ROSCD) 312,341,64974.9%133,538,549 USD
Myokardia Inc (MYOK) 3,218,89911.9%39,785,592 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%34,393,821 USD
Immune Design Corp (IMDZ) 917,4294.55%11,513,734 USD
Proteome Sciences plc (PRM) 38,0000.017%9,472 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 500.0001%1,104 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
SANOFI
GLAXOSMITHKLINE P..
ALLERGAN PLC
ELI LILLY AND CO
BAYER AG
ASTRAZENECA PLC
ABBOTT LABORATORI..
SHIRE PLC
TEVA PHARMACEUTIC..
-
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
MYLAN NV
CHUGAI PHARMACEUT..
Sector Pharmaceuticals
Sanofi : Connections
National Committee on United States-China Relations, Inc.
Montres CORUM Sàrl
Maremma SASU
Fondation pour l’Université de Lyon
Alliance Automotive Group SAS
The Johns Hopkins University
Financières SASA
Fondation de France
Piasa SA
Academie de l'air et de l'espace
National Academy of Engineering
Madrigall SA
Weinberg Capital Partners SAS
Pres héSam
Council on Foreign Relations, Inc.
Académie des Technologies
Sanofi-Aventis Europe SAS
Philipps University of Marburg
Sanofi-Aventis Participations SA
Académie Nationale de Médecine
Institute of Medicine
MedImmune LLC
Piasa Holding SAS
International Federation of Pharmaceutical Manufacturers A
Sanofi Pasteur Holding SA
Bordeaux University Foundation
Sanofi Pasteur Holding & Merial Ltd.
Pharmaceutical Research & Manufacturers of America
Fondation C.Génial
Sanofi-Aventis U.S. LLC
Fondation Lacoste
Financière Piasa SAS
L'Oréal Corporate Foundation
The Children's Aid Society, Inc.
Academie des Sports
King Abdullah University of Science & Technology
Académie des Sciences et Technologies
Warp Drive Bio LLC
Aventis Foundation
Research!America
Ruprecht-Karls-Universität Heidelberg
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem